Skip to content
Agree.net – Lifestyle
Author:
Oryzon Genomics, S.A.
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
June 11, 2026
ORYZON Initiates Patient Enrollment in IDEAL Phase II Trial of Iadademstat in Essential Thrombocythemia
June 2, 2026
Phillips & Associates Attorneys Named to 2026 Best Lawyers: Ones to Watch® in Employment Law
May 22, 2026
Phillips & Associates Attorneys Recognized in 2026 Best Lawyers in America® for Employment Law in New York
May 21, 2026
Phillips & Associates Ranked Among Top New York Employment Law Firms in 2026 Best Law Firms®
May 16, 2026
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
May 14, 2026
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
May 13, 2026
ORYZON to Participate in Upcoming Events in May and June
April 29, 2026
ORYZON Strengthens Vafidemstat Patent Portfolio With U.S. Notice of Allowance
March 25, 2026
ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax
March 23, 2026
1
2
Next Page
→